Sabrina Sorli-Gea

Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Alveolar type II cell therapy ameliorates pulmonary fibrosis by reprogramming macrophage activation.

Alveolar type II cell therapy ameliorates pulmonary fibrosis by reprogramming macrophage activation.

Journal: Inflammation and regeneration

Published: December 30, 2025

Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model.

Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model.

Journal: Molecular therapy. Methods & clinical development

Published: October 11, 2023

Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement.

Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement.

Journal: Gene therapy

Published: May 12, 2023

Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.

Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: October 14, 2021

Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models.

Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models.

Journal: Cancers

Published: May 27, 2021

Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma.

Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma.

Journal: Cancer research

Published: February 22, 2019

Mutations in TIMM50 cause severe mitochondrial dysfunction by targeting key aspects of mitochondrial physiology.

Mutations in TIMM50 cause severe mitochondrial dysfunction by targeting key aspects of mitochondrial physiology.

Journal: Human mutation

Published: October 10, 2018

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Journal: Thorax

Published: January 27, 2016

New Roles for Corticosteroid Binding Globulin and Opposite Expression Profiles in Lung and Liver.

New Roles for Corticosteroid Binding Globulin and Opposite Expression Profiles in Lung and Liver.

Journal: PloS one

Published: September 07, 2015

Minocycline inhibits peritoneal macrophages but activates alveolar macrophages in acute pancreatitis.

Minocycline inhibits peritoneal macrophages but activates alveolar macrophages in acute pancreatitis.

Journal: Journal of physiology and biochemistry

Published: May 18, 2015

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Journal: The Lancet. Respiratory medicine

Published: May 05, 2015

Lipids generated during acute pancreatitis increase inflammatory status of macrophages by interfering with their M2 polarization.

Lipids generated during acute pancreatitis increase inflammatory status of macrophages by interfering with their M2 polarization.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: February 03, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026